Silver(I) and copper(I) complexes supported by fully fluorinated 1,3,5-triazapentadienyl ligands.

Synthesis of the perfluorinated 1,3,5-triazapentadiene [N{(CF(3))C(C(6)F(5))N}(2)]H and the use of its conjugate base as a supporting ligand for the isolation of silver(i) and copper(i) complexes are reported. Some of the related chemistry involving [N{(C(3)F(7))C(C(6)F(5))N}(2)](-) (that has bulkier -C(3)F(7) groups on the 1,3,5-triazapentadienyl ligand backbone) is also presented. X-ray crystallographic data show a wide variety of structures ranging from intermolecular, hydrogen-bonded chain structure for [N{(CF(3))C(C(6)F(5))N}(2)]H with a twisted W-shaped N(3)C(2) core, monomeric [N{(CF(3))C(C(6)F(5))N}(2)]Ag(CN(t)Bu)(2) and [N{(C(3)F(7))C(C(6)F(5))N}(2)]Ag(CN(t)Bu)(2) where the κ(1)-bonded triazapentadienyl ligand bonding to the metal fragment via the central nitrogen atom, monomeric [N{(CF(3))C(C(6)F(5))N}(2)]Ag(PPh(3))(2) and [N{(C(3)F(7))C(C(6)F(5))N}(2)]Ag(PPh(3))(2) that feature κ(1)-bonded triazapentadienyl ligand bonding to the metal fragment via one of the terminal nitrogen atoms, to that of the monomeric [N{(CF(3))C(C(6)F(5))N}(2)]Cu(CN(t)Bu)(2) containing a κ(2)-bonded triazapentadienyl ligand and a U-shaped NCNCN ligand backbone. The isocyanide adducts show relatively high ν(CN) values in the IR spectra.

Scorpionates bearing nitro substituents: mono-, bis- and tris-(3-nitro-pyrazol-1-yl)borate ligands and their copper(I) complexes.

Two scorpionates sodium trihydro(3-nitro-pyrazol-1-yl)borate (Na[H(3)B(3-(NO(2))pz)]) and sodium hydrotris(3-nitro-pyrazol-1-yl)borate (Na[HB(3-(NO(2))pz)(3)]), featuring electron withdrawing substituents, have been synthesized in high yield starting from 3(5)-nitropyrazole and sodium borohydride. The treatment of CuX (X = (CH(3)CN)(4)PF(6), Cl or I) with Na[H(3)B(3-(NO(2))pz)], Na[HB(3-(NO(2))pz)(3)] or the related bis(pyrazolyl)borate Na[H(2)B(3-(NO(2))pz)(2)] in the presence of triphenylphosphine or tert-butyl isocyanide afforded the corresponding (azolyl)borate supported copper(I) triphenylphosphine or tert-butyl isocyanide adducts. These compounds have been characterized by elemental analyses, FT-IR, ESI-MS and multinuclear NMR spectroscopy. X-Ray crystal structures of [H(3)B(3-(NO(2))pz)]Cu[P(C(6)H(5))(3)](2), [H(2)B(3-(NO(2))pz)]Cu(CNt-Bu)(2), and [HB(3-(NO(2))pz)(3)]Cu[P(C(6)H(5))(3)], as well as that of the {[HB(3-(NO(2))pz)(3)]Na}(4) are also reported. The latter displays a particularly interesting tetrameric structure with each tris(pyrazolyl)borate adopting an unusual inverted configuration and serves as a bridging ligand for three different sodium ions.

In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.

Monocationic hydrophilic complexes [Cu(thp)4](+) 3 and [Cu(bhpe)2](+) 4 were synthesized by ligand exchange reactions starting from the labile [Cu(CH3CN)4][PF6] precursor in the presence of an excess of the relevant hydrophilic phosphine. Complexes 3 and 4 were tested against a panel of several human tumor cell lines. Complex 3 has been shown to be about 1 order of magnitude more cytotoxic than cisplatin. Chemosensitivity tests performed on cisplatin and multidrug resistance phenotypes suggested that complex 3 acts via a different mechanism of action than the reference drug. Different short-term proliferation assays suggested that lysosomal damage is an early cellular event associated with complex 3 cytotoxicity, probably mediated by an increased production of reactive oxygen species. Cytological stains and flow cytometric analyses indicated that the phosphine copper(I) complex is able to inhibit the growth of tumor cells via G2/M cell cycle arrest and paraptosis accompanied with the loss of mitochondrial transmembrane potential.

Small scorpionate ligands: silver(I)-organophosphane complexes of 5-CF(3)-substituted scorpionate ligand combining a B-H...Ag coordination motif.

The first 5-substituted trihydro(azolyl)borate system, the sodium trihydro(5-CF3-pyrazol-1-yl)borate, Na[H3B(5-(CF3)pz)], has been synthesized by the reaction of 3-trifuoromethyl-pyrazole with NaBH4 in high yield. Na[H3B(5-(CF3)pz)] reacts with AgNO3 in the presence of monodentate tertiary phosphanes PR3 (PR3=P(C6H5)3, P(p-C6H4CH3)3, P(m-C6H4CH3)3, P(o-C6H4CH3)3, or PCH3(C6H5)2) to afford silver(I) bis(phosphane) adducts. These compounds have been characterized by elemental analyses, FTIR, ESI-MS, and multinuclear (1H, 19F, and 31P) NMR spectroscopy. Solid-state structures of {[H3B(5-(CF3)pz)]Ag[P(C6H5)3]2} and {[H3B(5-(CF3)pz)]Ag[P(p-C6H4CH3)3]2} are also reported. They feature kappa2-N,H-bonded trihydro(pyrazolyl)borate ligands and pseudo-tetrahedral silver atoms.

Silver(I)-organophosphane complexes of electron withdrawing CF3- or NO2-substituted scorpionate ligands.

New silver(I) complexes have been synthesized from the reaction of AgNO(3), monodentate tertiary phosphanes PR(3) (PR(3) = P(C(6)H(5))(3), P(o-C(6)H(4)CH(3))(3), P(m-C(6)H(4)CH(3))(3), P(p-C(6)H(4)CH(3))(3), PCH(3)(C(6)H(5))(2)) and two novel electron withdrawing ligands: potassium dihydrobis(3-nitropyrazol-1-yl)borate and potassium dihydrobis(3-trifluoromethylpyrazol-1-yl)borate. These compounds have been characterized by elemental analyses, FT-IR, ESI-MS and multinuclear ((1)H, (19)F and (31)P) NMR spectroscopy. Solid state structures of the potassium salts K[H(2)B(3-(NO(2))pz)(2)] and K[H(2)B(3-(CF(3))pz)(2)] have been reported. They form polymeric networks due to intermolecular contacts of various types between the potassium ion and atoms of the neighboring molecules. The silver adducts [H(2)B(3-(NO(2))pz)(2)]Ag[P(C(6)H(5))(3)](2) and [H(2)B(3-(NO(2))pz)(2)]Ag[P(p-C(6)H(4)CH(3))(3)] have pseudo tetrahedral and trigonal planar silver sites, respectively. The bis(pyrazolyl)borate ligand acts as a kappa(2)-N(2) donor. The nitro-substituents are coplanar with the pyrazolyl rings in all these adducts indicating efficient electron delocalization between the two units. The [H(2)B(3-(CF(3))pz)(2)]Ag[P(C(6)H(5))(3)] complex has been obtained from re-crystallization of {[H(2)B(3-(CF(3))pz)(2)]Ag[P(C(6)H(5))(3)](2)} in a dichloromethane-diethyl ether solution; it is a three-coordinate, trigonal planar silver complex.

Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.

The new sodium bis(1,2,4-triazol-1-yl)acetate ligand, Na[HC(CO(2))(tz)(2)], has been prepared in methanol solution by using 1,2,4-triazole, dibromoacetic acid, and NaOH. Treatment of the [Cu(CH(3)CN)(4)][PF(6)] acceptor with Na[HC(CO(2))(tz)(2)] or Na[HC(CO(2))[(pz(Me2))(2)] in the presence of the tris(hydroxymethyl)phosphine coligand in methanol/acetonitrile solutions produced unprecedented mononuclear copper(I) complexes of the [L(n)]Cu[P(CH(2)OH)(3)](2) (L(1), 2; L(2), 3) [(CH(3)CN)(2)Cu(P(CH(2)OH)(3))(2)]PF(6), 4. These compounds have been characterized by elemental analyses, FTIR, ESI-MS, and multinuclear (1H and 31P) NMR spectral data. The new copper(I) complexes were tested for their cytotoxic properties against a panel of several human tumor cell lines. The results reported here indicate that all the complexes showed in vitro antitumor activity similar or better than that of cisplatin, the most used metal-based antitumor drug. In particular, [HC(CO(2))(pz(Me2))(2)]Cu[P(CH(2)OH)(3)](2), 3 showed IC(50) values markedly lower than the reference compound against all tumor cell lines. Chemosensitivity tests performed on cisplatin sensitive and resistant cell lines have demonstrated that all these Cu(I) complexes were able to overcome cisplatin resistance, supporting the hypothesis of a different mechanism of action compared to that exhibited by the reference drug. Flow cytometric analysis on 2008 human ovarian carcinoma cells revealed that complex 3, chosen as the best candidate, induced a marked enlargement of both cell size and granularity, and a significant increase in the fraction of G2/M cells that, differently from cisplatin, was not accompanied by the appearance of a relevant sub-G1 fraction. Besides, no evidence of caspase-3 activation was detected in cells treated with complex 3. We hypothesize that the cytotoxic activity of the new copper(I) complex may be correlated to its ability to trigger paraptosis, a nonapoptotic mechanism of cell death.

New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity.

New copper(I) complexes of the type [H(2)B(tz(NO2))(2)]Cu[PR(3)](2) (1-5), [H(2)B (tz(NO2))(2)]Cu[dppe] (6) and [H(2)B(tz(NO2))(2)]Cu[PR(3)] (7, 8) have been synthesized from the reaction of CuCl, potassium dihydrobis(3-nitro-1,2,4-triazol-1-yl)borate, K[H(2)B (tz(NO2))(2)], and mono- or bi-dentate tertiary phosphanes. The complexes obtained have been characterized by elemental analyses and FT-IR in the solid state, and by NMR ((1)H and (31)P{(1)H}) spectroscopy in solution. Selected complexes 1, 3 and 5 have also been tested against a panel of several human tumor cell lines in order to evaluate their cytotoxic activity. Complexes 1 and 5 showed IC(50) values appreciably lower than those exhibited by cisplatin, the most used metal-based antitumor drug. It is worth noting that all three tested Cu(I) complexes appear to be particularly effective against A549 carcinoma cells that are resistant to cisplatin treatment.

The first nitro-substituted heteroscorpionate ligand.

The new dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand, [H2B(tzNO2)2]-, has been synthesized in dimethylacetamide solution, using 3-nitro-1,2,4-triazole and KBH4 through careful temperature control, and characterized as its potassium salt. The zinc(II) and cadmium(II) complexes, {M[H2B(tzNO2)2]Cl(H2O)2}, have been prepared by metathesis of [H2B(tzNO2)2]K with ZnCl2 and CdCl2, respectively. The complexes likely contain a metal core in which the ligand is coordinated to the metal ions in the K2-N,N' or K4-N,N',O,O' fashion. A single-crystal structural characterization is reported for the potassium dihydrobis(3-nitro-1,2,4-triazolyl)borate. The potassium salt is polymeric and shows several K...N and K...O interactions.

Synthesis, characterization and antioxidant activity of new copper(I) complexes of scorpionate and water soluble phosphane ligands.

New copper(I) complexes have been synthesised from the reaction of CuCl with potassium hydrotris(4-bromo-1H-pyrazol-1-yl)borate, KTp4Br or lithium bis(3,5-dimethylpyrazol-1-yl)acetate, Li[L2CO2] ligands and 4- or 2-(diphenylphosphane)benzoic acid or tris(m-sulfonatophenyl)posphine trisodium salt (TPPTS) coligands. The complexes obtained have been characterized by elemental analyses and FT-IR in the solid state, and by NMR (1H and 31P[1H]) and electrospray mass spectrometry (ESI-MS) in solution. Single crystal structural characterisation was undertaken for the [Cu[PPh2(4-C6H4COOH)](Tp4Br)] derivative, an interesting dimeric supramolecular assembly. A chemiluminescence study has demonstrated the superoxide scavenging activity of these new copper complexes. The Comet assay was used to evaluate the impairment of DNA in rat epithelial cells exposed to different reactive nitrogen species. In addition, the same complexes were included in this study to determine their efficacy as antioxidants in mitigating oxidative DNA damage. The parameter tail moment, used as an index of DNA damage, showed that the complex [Cu[PPh2(4-C6H4COOH)](Tp4Br)] remarkably inhibited DNA strand breaks induced by the different nitrogen oxide species. The other copper complexes under study showed a different ability to reduce tail moment values depending on the type of RNOS donor used.

Synthesis and characterization of new copper(I) complexes containing 4-(diphenylphosphane)benzoic acid and "scorpionate" ligands with "in vitro" superoxide scavenging activity.

New copper(I) complexes have been synthesised from the reaction of CuCl with 4-(diphenylphosphane)benzoic acid and lithium tris(1H-pyrazol-1-yl)methanesulfonate, Li(SO(3))C(pz)(3), sodium hydrotris(3-trifluoromethyl-1H-pyrazol-1-yl)borate, NaHB[3-(CF(3))pz](3), potassium dihydrobis(1H-1,2,4-triazol-1-yl)borate, KH(2)B(tz)(2), hydrotris(1H-1,2,4-triazol-1-yl)borate, KHB(tz)(3), sodium hydrotris(1H-pyrazol-1-yl)borate, NaHB(pz)(3), potassium hydrotris(3,5-dimethyl-1H-pyrazol-1-yl)borate KHB(3,5-Me(2)Pz)(3) or potassium hydrotris(4-bromo-1H-pyrazol-1-yl)borate KHB(4-Brpz)(3). The complexes obtained have been characterized by elemental analyses and FT-IR in the solid state, and by NMR (1H and 31P[(1)H]) spectroscopy and conductivity measurements in solution. The solution data are consistent with partial dissociation of the sterically hindered complexes by way of breaking of Cu-P and Cu-N bonds. Electrospray mass spectrometry has been used to investigate the relative properties of the 4-(diphenylphosphane)benzoic acid and of the "scorpionate" ligands towards copper(I) ions. Chemiluminescence technique was used to evaluate the superoxide scavenging activity of these new copper complexes.